Friday, November 4, 2022
10:32 AM EST – Medicenna Therapeutics Corp. : Announced its financial results and operational highlights for the quarter ended September 30, 2022. Net loss was $0.9 million, or ($0.01) per share, compared to a loss of $8.2 million, or ($0.15) per share for the quarter ended September 30, 2021. Medicenna Therapeutics Corp. (T.MDNA) shares were down $0.02 at 0.9.
Stocks in Play: Medicenna Therapeutics Corp., Fri, 04 Nov 2022 10:42:06 EST